ARMISTICE CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for CITIUS ONCOLOGY, INC. Common stock, $0.0001 par value (CTOR)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: CITIUS ONCOLOGY, INC. Common stock, $0.0001 par value
Symbol: CTOR
Shares outstanding: 80,864,905 shares
Disclosed Ownership: 8,078,404 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 21:52:51 UTC
Date of event: 31 Dec 2025
Previous filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	10%	8,078,404	0	8,078,404	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	10%	8,078,404	0	8,078,404	/s/ Steven Boyd	Steven Boyd